Biomarkers for Traumatic Brain Injury Proceedings of a Workshop (2023) / Chapter Skim
Currently Skimming:
Appendix B: Workshop Task and Agenda
Appendix B: Workshop Task and Agenda
Pages 59-62
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 59... ...
. Presentations and discussions may be designed to • Review the landscape of TBI biomarkers, including blood-based, imaging-based, and other types of relevant physiological markers; • Explore clinical needs, challenges, and potential opportunities to advance implementation of Food and Drug Administration (FDA)
|
From page 60... ...
Ramon Diaz-Arrastia, University of Pennsylvania Perspectives from the TBI Community on the Role of Biomarkers in Addressing Unmet Needs Rachel Lazarus, AARP Jeffrey Bazarian, University of Rochester Lessons from Validation and Use of Biomarkers to Inform Cardiology Care and Research Alan Wu, San Francisco General Hospital Discussion 10:40–11:00 am Break
|
From page 61... ...
APPENDIX B 61 11:00–12:40 pm SESSION 2: MAJOR CLASSES OF TBI BIOMARKERS Moderator: Luca Marinelli, GE Research Syntheses of several classes of TBI biomarkers, including where on the continuum of care such biomarkers have demonstrated utility, barriers to their implementation in clinical practice, and open research gaps and questions Neuroimaging Biomarkers Elisabeth Wilde, University of Utah Biomarkers Detectable in Blood Jessica Gill, Johns Hopkins University Electrophysiological Biomarkers Paul Rapp, Uniformed Services University and University of California, Irvine Other Physiological Markers Christina Master, University of Pennsylvania Discussion 12:40–1:30 pm Lunch 1:30–2:30 pm SESSION 3: DEVELOPMENT OF BIOMARKERS IN THE TRANSLATIONAL PIPELINE Moderator: Stuart Hoffman, Department of Veterans Affairs Pharmacodynamic Response Biomarkers Patrick Kochanek, University of Pittsburgh Combining Multimodal Information to Improve Diagnosis, Prognostication, and Understanding of Longer-Term Outcomes David Okonkwo, University of Pittsburgh Discussion 2:30–2:50 pm Break
|
From page 62... ...
Panelists: Martin Schreiber, Oregon Health and Science University Beth McQuiston, Abbott Laboratories Allison Kumar, Arina Consulting Carol Taylor-Burds, National Institute of Neurological Disorders and Stroke (NINDS) Narayan Iyer, Biomedical Advanced Research and Development Authority (BARDA)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.